Current
469.30 €
+1.38% today
Start price
459.95 €
Target price
519.06 €
+44.4% to target
End price
359.50 €
Performance (%)
-21.84%
Return to target
+44.4%
Confidence
50%
Time horizon
2025-10-17
Performance since start
How it ranks
- #232 Rank 232 of 242 by performance
- 231 ratings for this instrument performed better
- 43 other running ratings for this instrument
Summary
This prediction ended on 18.10.25 with a price of €359.50. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -21.84%. UBS_Group_AG has 50% into this prediction
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.